RxDoctor Payments Data

Joseph Markenson

New York, NYNPI 1164485637

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $121,898 of the $176,717 with a category attached, or 69.0%. 12 manufacturers reported payments, led by AbbVie at 37.7% of the total. Reporting peaked in 2019 at $85,200 and has fallen 100.0% since, to $32 in 2023.

$176,717in general payments, 2019–2025

Across 209 payments — averaging $845.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$67K
  • Amgen$22K
  • Sanofi$17K
  • Bristol Myers Squibb$16K
  • Lilly USA, LLC$15K
  • E.r. Squibb & Sons, L.L.C.$15K
  • plus $26K from 6 others
$19,950in research payments, 2019–2025

Across 4 payments — averaging $4987.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$20K

What the payments were for

  • Consulting fees$36,43821%
  • Speaking & faculty fees$121,89869%
  • Travel & lodging$13,8758%
  • Food & beverage$4,4443%
  • Education$620%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie78$66,627
Amgen(2 entities)26$21,857
Sanofi13$17,161
Bristol Myers Squibb20$15,700
Lilly USA, LLC26$15,038
E.r. Squibb & Sons, L.L.C.3$14,675
Novartis24$9,405
Regeneron Healthcare Solutions, Inc.11$8,790
GSK4$4,336
EMD Serono, Inc.1$3,000
Johnson & Johnson1$87
Pfizer2$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →